Raphael Pharmaceutical (RAPH) Other Accumulated Expenses (2025)
Raphael Pharmaceutical (RAPH) posted Other Accumulated Expenses of $297700.0 for Q4 2025.
Raphael Pharmaceutical (RAPH) Other Accumulated Expenses (2025) Analysis & Trends
Raphael Pharmaceutical has reported Other Accumulated Expenses for 1 years, with the latest figure at $297700.0 in Q4 2025.
- Quarterly Other Accumulated Expenses changed N/A year-over-year to $297700.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $297700.0 (changed N/A YoY) and the FY2025 annual result came in at $297700.0, changed N/A from the prior year.
- Other Accumulated Expenses steadied at $297700.0 in Q4 2025 per RAPH's latest filing.
- Over five years, Other Accumulated Expenses peaked at $297700.0 in Q4 2025 and troughed at $297700.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Raphael Pharmaceutical | 28.25 Mn | 28.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 297,700.00 |